Vineet Laborator

{
  "main_header": {
    "sid": 1003496,
    "name": "Vineet Laborator",
    "stock_name": "Vineet Laborator",
    "full_name": "Vineet Laboratories Ltd",
    "name_url": "stocks-analysis/vineet-laborator",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.66",
    "chg": -0.44,
    "chgp": "-1.46%",
    "dir": -1,
    "prev_price": "30.10",
    "mcapval": "58.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543298,
    "symbol": "VINEETLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE505Y01010",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "81.15 k",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vineet-laborator-1003496-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vineet Laboratories Ltd Upgraded to Sell on Mildly Bullish Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-upgraded-to-sell-on-mildly-bullish-technical-signals-3895951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VineetLaborator_mojoScore_3895951.png",
        "date": "2026-03-17 08:37:36",
        "description": "Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s technical trend has improved to mildly bullish, prompting a reassessment of its outlook, even as financial performance remains flat and profitability metrics continue to disappoint."
      },
      {
        "title": "Vineet Laboratories Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-downgraded-to-strong-sell-amidst-weak-fundamentals-and-technical-setbacks-3884556",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VineetLaborator_mojoScore_3884556.png",
        "date": "2026-03-11 08:22:54",
        "description": "Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 10 March 2026, reflecting deteriorating technical indicators and weak fundamental performance. The downgrade is driven by a combination of sideways technical trends, poor financial results, unfavourable valuation metrics, and declining quality scores, signalling heightened risk for investors in this Pharmaceuticals & Biotechnology stock."
      },
      {
        "title": "Vineet Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-is-rated-sell-3873053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/VineetLaborator_mojoScore_3873053.png",
        "date": "2026-03-05 10:10:53",
        "description": "Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vineet Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-is-rated-sell-3848110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VineetLaborator_mojoScore_3848110.png",
        "date": "2026-02-20 10:10:49",
        "description": "Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Vineet Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vineet-laboratories-ltd-3833789",
        "imagepath": "",
        "date": "2026-02-11 23:17:07",
        "description": "The next results date for Vineet Laboratories Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "Vineet Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-technical-signals-3828052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VineetLaborator_mojoScore_3828052.png",
        "date": "2026-02-09 08:20:25",
        "description": "Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 February 2026, reflecting deteriorating fundamentals, challenging valuation metrics, a negative financial trend, and mixed technical signals. The pharmaceutical company’s recent performance and outlook have raised concerns among analysts, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Vineet Laboratories Ltd Upgraded to Sell on Improved Technicals Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-upgraded-to-sell-on-improved-technicals-despite-weak-fundamentals-3815826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/VineetLaborator_mojoScore_3815826.png",
        "date": "2026-02-02 08:46:38",
        "description": "Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 February 2026, driven primarily by a marked improvement in technical indicators. However, the company continues to face significant challenges on the fundamental and financial fronts, with deteriorating profitability and weak long-term growth prospects weighing heavily on investor sentiment."
      },
      {
        "title": "Vineet Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-is-rated-strong-sell-3803958",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/VineetLaborator_mojoScore_3803958.png",
        "date": "2026-01-25 10:10:42",
        "description": "Vineet Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Vineet Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laboratories-ltd-fallingrising-3779374",
        "imagepath": "",
        "date": "2026-01-03 01:58:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>The stock has underperformed significantly in the short term, falling by 9.43% over the past week while the Sensex gained 0.85%. Despite a positive one-month return of 16.34%, the stock’s year-to-date performance remains negative at -6.64%, contrasting with the Sensex’s modest 0.64% gain. Over the last year, Vineet Laboratories has declined by 16.61%, whereas the Sensex has risen by 7.28%, highlighting the stock’s persistent underperformance relative to the broader market.</p>\n<p>On the day in question, the stock underperformed its sector by 4.76%, marking the seventh consecutive day of losses and a cumulative decline of 13.13% during this period. Intraday, the share price touched a low of ₹33.74, down 5.68%, with heavier trading v..."
      }
    ],
    "total": 280,
    "sid": "1003496",
    "stock_news_url": "https://www.marketsmojo.com/news/vineet-laboratories-1003496"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "We enclose herewith the copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31 2025 published in following Newspapers on February 16 2026 1. Financial Express (English Language) 2. Nava Telangana (Telugu Language)",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "14-Feb-2026",
      "details": "The Board of Directors of the company in its meeting held today i.e. Saturday February 14 2026 has: considered and approved the unaudited standalone financial results of the company for the third quarter and nine months ended on December 31 2025 along with the Limited Review Report submitted by the Statutory Auditors. approved the proposed payments and ratified advances made to certain vendors towards Quality Control equipment and Purified RO Water equipment i.e. for the purpose(s) not mentioned in the Rights Issue Letter of Offer dated December 17 2025. However these payments made in February 2026 are for the equipment to be installed in the new production facility which was mentioned in the Letter of Offer.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone Financial Results Along With The Limited Review Report For The Period Ended On December 31 2025",
      "datetime": "14-Feb-2026",
      "details": "The Board of Directors in its meeting held today i.e on February 14 2026 has considered and approved the Unaudited Standalone Financial Results along with the Limited Review Report submitted by the Statutory Auditors for the Third Quarter ended on December 31 2025 .",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 22",
          "dt": "2022-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has announced <strong>13:12</strong> rights issue, ex-date: 23 Dec 25",
          "dt": "2025-12-23",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Vineet Laboratories Ltd Upgraded to Sell on Mildly Bullish Technical Signals

2026-03-17 08:37:36

Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 March 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s technical trend has improved to mildly bullish, prompting a reassessment of its outlook, even as financial performance remains flat and profitability metrics continue to disappoint.

Read full news article

Vineet Laboratories Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Technical Setbacks

2026-03-11 08:22:54

Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 10 March 2026, reflecting deteriorating technical indicators and weak fundamental performance. The downgrade is driven by a combination of sideways technical trends, poor financial results, unfavourable valuation metrics, and declining quality scores, signalling heightened risk for investors in this Pharmaceuticals & Biotechnology stock.

Read full news article

Vineet Laboratories Ltd is Rated Sell

2026-03-05 10:10:53

Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vineet Laboratories Ltd is Rated Sell

2026-02-20 10:10:49

Vineet Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

When is the next results date for Vineet Laboratories Ltd?

2026-02-11 23:17:07

The next results date for Vineet Laboratories Ltd is scheduled for 14 February 2026....

Read full news article

Vineet Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Technical Signals

2026-02-09 08:20:25

Vineet Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 6 February 2026, reflecting deteriorating fundamentals, challenging valuation metrics, a negative financial trend, and mixed technical signals. The pharmaceutical company’s recent performance and outlook have raised concerns among analysts, prompting a reassessment of its investment appeal.

Read full news article

Vineet Laboratories Ltd Upgraded to Sell on Improved Technicals Despite Weak Fundamentals

2026-02-02 08:46:38

Vineet Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 February 2026, driven primarily by a marked improvement in technical indicators. However, the company continues to face significant challenges on the fundamental and financial fronts, with deteriorating profitability and weak long-term growth prospects weighing heavily on investor sentiment.

Read full news article

Vineet Laboratories Ltd is Rated Strong Sell

2026-01-25 10:10:42

Vineet Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Vineet Laboratories Ltd falling/rising?

2026-01-03 01:58:17

Recent Price Movement and Market Performance

The stock has underperformed significantly in the short term, falling by 9.43% over the past week while the Sensex gained 0.85%. Despite a positive one-month return of 16.34%, the stock’s year-to-date performance remains negative at -6.64%, contrasting with the Sensex’s modest 0.64% gain. Over the last year, Vineet Laboratories has declined by 16.61%, whereas the Sensex has risen by 7.28%, highlighting the stock’s persistent underperformance relative to the broader market.

On the day in question, the stock underperformed its sector by 4.76%, marking the seventh consecutive day of losses and a cumulative decline of 13.13% during this period. Intraday, the share price touched a low of ₹33.74, down 5.68%, with heavier trading v...

Read full news article

View All News